WB

Wolfgang Brysch

MA Metriopharm Ag: 7 patents #1 of 14Top 8%
Overall (All Time): #269,167 of 4,157,543Top 7%
17
Patents All Time

Issued Patents All Time

Showing 1–17 of 17 patents

Patent #TitleCo-InventorsDate
12122753 Method for solubilizing 5-amino-2,3-dihydro-1,4-phthalazinedione Ingo Saar, Jörg Von Wegerer 2024-10-22
11497760 Method for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agents Ingo Saar, Jörg Von Wegerer 2022-11-15
11207256 Method for solubilizing poorly water-soluble cosmetic agents Ingo Saar, Jörg von Wegerer 2021-12-28
11203575 Methhod for producing a crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione Thomas Martin, Josef Breu, Juliane Fleissner, Jörg Von Wegerer 2021-12-21
11111218 Crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione Thomas Martin, Josef Breu, Juliane Fleissner, Jörg Von Wegerer 2021-09-07
11007192 Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the treatment of chronic progressive multiple sclerosis Astrid Kaiser, Claudia Van Laak, Beate Ludescher, Maliha Shah, Jörg Von Wegerer 2021-05-18
10588896 Agents for the treatment of retroviral infectious diseases Ulrich Schubert, Christian Setz, Jörg Von Wegerer 2020-03-17
10258620 Crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said form Thomas Martin, Josef Breu, David Kosel, Beate Ludescher, Michael Niedermaier +1 more 2019-04-16
9079863 Crystalline forms for 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said forms Josef Breu, Astrid Kaiser, Beate Ludescher, Gerrit Maass, Thomas Martin +2 more 2015-07-14
8772294 Crystalline forms for 5-amino-2, 3-dihydrophthalazine-1, 4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said forms Josef Breu, Astrid Kaiser, Beate Ludescher, Gerrit Maass, Thomas Martin +2 more 2014-07-08
8629117 Method for stimulating the immune system Karl-Hermann Schlingensiepen, Reimar Schlingensiepen 2014-01-14
7667027 Antisense-oligonucleotides for the treatment of immuno-suppressive effects of transforming growth factor-β (TGF-β) Georg-Ferdinand Schlingensiepen, Karl-Hermann Schlingensiepen, Reimar Schlingensiepen, Ulrich Bogdahn 2010-02-23
7563778 Antisense oligonucleotide preparation method Karl-Hermann Schlingensiepen 2009-07-21
7326783 Pharmaceutical composition comprising antisense-nucleic acid for prevention and/or treatment of neuronal injury, degeneration and cell death and for the treatment of neoplasms Georg-Ferdinand Schlingensiepen, Reimar Schlingensiepen, Karl-Hermann Schlingensiepen 2008-02-05
6972171 Antisense oligonucleotide preparation method Karl-Hermann Schlingensiepen 2005-12-06
6455689 Antisense-oligonucleotides for transforming growth factor-&bgr; (TGF-&bgr;) Georg-Ferdinand Schlingensiepen, Karl-Hermann Schlingensiepen, Reimar Schlingensiepen, Ulrich Bogdahn 2002-09-24
6365345 Antisense nucleic acids for the prevention and treatment of disorders in which expression of c-erbB plays a role Karl-Hermann Schlingensiepen, Reimar Schlingensiepen, Georg-Ferdinand Schlingensiepen 2002-04-02